Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

Yuki Kitamura (2259145)
Ryoko Usami (3686107)
Sahoko Ichihara (3431573)
Hirotaka Kida (555666)
Masayuki Satoh (555661)
Hidekazu Tomimoto (110968)
Mariko Murata (2742784)
Shinji Oikawa (1819162)

January 2017

Objectives: Alzheimer’s disease (AD) is the most common cause of dementia in elderly perso...

Protein biomarkers for the diagnosis of Alzheimer's disease at different stages of neurodegeneration

Pérez, Mar
Hernández, Félix
Ávila, Jesús

April 2021

Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...

Are Blood-Based Protein Biomarkers for Alzheimer’s Disease also Involved in Other Brain

Disorders A Systematic Review
Justin Tao
Wen Chiama
Richard James
Butler Dobsonb
Steven John Kiddleb
Martina Sattleckerb C

January 2014

Abstract. Background: Alzheimer’s disease (AD) biomarkers are urgently needed for both early and acc...

Replication study of plasma proteins relating to Alzheimer's pathology.

Shi, L.
Winchester, L.M.
Westwood, S.
Baird, A.L.
Anand, S.N.
Buckley, N.J.
Hye, A.
Ashton, N.J.
Bos, I.
Vos, SJB
Kate, M.T.
Scheltens, P.
Teunissen, C.E.
Vandenberghe, R.
Gabel, S.
Meersmans, K.
Engelborghs, S.
De Roeck, E.E.
Sleegers, K.
Frisoni, G.B.
Blin, O.
Richardson, J.C.
Bordet, R.
Molinuevo, J.L.
Rami, L.
Wallin, A.
Kettunen, P.
Tsolaki, M.
Verhey, F.
Lléo, A.
Sala, I.
Popp, J.
Peyratout, G.
Martinez-Lage, P.
Tainta, M.
Johannsen, P.
Freund-Levi, Y.
Frölich, L.
Dobricic, V.
Legido-Quigley, C.
Barkhof, F.
Andreasson, U.
Blennow, K.
Zetterberg, H.
Streffer, J.
Lill, C.M.
Bertram, L.
Visser, P.J.
Kolb, H.C.
Narayan, V.A.
Lovestone, S.
Nevado-Holgado, A.J.

September 2021

This study sought to discover and replicate plasma proteomic biomarkers relating to Alzheimer's dise...

Candidate Blood Proteome Markers of Alzheimer’s Disease Onset and Progression: A Systematic Review and Replication Study

Steven J. Kiddlea
Martina Sattleckera
Petroula Proitsia
Andrew Simmonsa
Eric Westmanc
Chantal Bazeneta
Sally K. Nelsond
Stephen Williamsd
Angela Hodgesa
Caroline Johnstona
Hilkka Soininene
Iwona Kłoszewskaf
Patrizia Mecoccig
Magda Tsolakih
Bruno Vellasi
Stephen Newhousea
Simon Lovestonea
Richard J. B. Dobsona

January 2013

Abstract. A blood-based protein biomarker, or set of protein biomarkers, that could predict onset an...

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

Payam Emami Khoonsari (3181767)
Anna Häggmark (755022)
Maria Lönnberg (3181770)
Maria Mikus (3181764)
Lena Kilander (470275)
Lars Lannfelt (333066)
Jonas Bergquist (203170)
Martin Ingelsson (252308)
Peter Nilsson (3305)
Kim Kultima (14963)
Ganna Shevchenko (280676)

March 2016

<div>Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of...

Data from: Analysis of the cerebrospinal fluid proteome in Alzheimer's disease

Khoonsari, Payam Emami
Häggmark, Anna
Lönnberg, Maria
Mikus, Maria
Kilander, Lena
Lannfelt, Lars
Bergquist, Jonas
Ingelsson, Martin
Nilsson, Peter
Kultima, Kim
Shevchenko, Ganna

April 2016

Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of dementi...

Summary of previous studies showing changes in acute phase proteins in Alzheimer’s disease.

Tharusha Jayasena (704509)
Anne Poljak (158842)
Nady Braidy (261733)
George Smythe (704510)
Mark Raftery (704511)
Mark Hill (704512)
Henry Brodaty (158887)
Julian Trollor (704513)
Nicole Kochan (704514)
Perminder Sachdev (377263)

March 2015

Summary of previous studies showing changes in acute phase proteins in Alzheimer’s disease.</p

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Sattlecker, Martina
Kiddle, Steven J.
Newhouse, Stephen
Proitsi, Petroula
Nelson, Sally
Williams, Stephen
Johnston, Caroline
Killick, Richard
Simmons, Andrew
Westman, Eric
Hodges, Angela
Soininen, Hilkka
Kłoszewska, Iwona
Mecocci, Patrizia
Tsolaki, Magda
Vellas, Bruno
Lovestone, Simon
Dobson, Richard J.B.

November 2014

AbstractBlood proteins and their complexes have become the focus of a great deal of interest in the ...

IOS Press The use of proteomics in biomarker discovery in neurodegenerative diseases

Pia Davidssona

August 2016

Abstract. Biomarkers for neurodegenerative diseases should reflect the central pathogenic processes ...

Proteomic-based Signature of Brain-related Proteins as Novel Candidate Biomarkers for Alzheimer’s Disease Diagnosis

Begcevic, Ilijana

June 2018

Alzheimer’s disease (AD) is the most common type of dementia characterized by the progressive memory...

Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration

Pérez, Mar
Hernández, Félix
Ávila, Jesús

September 2020

Characterization of functional protein complexes from Alzheimer’s disease and healthy brain by mass spectrometry-based proteome analysis

Beena Hasan
Ayesha Khan
Christof Lenz
Abdul R. Asif
Nikhat Ahmed

July 2021

Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...

The plasma peptides of Alzheimer’s disease

Florentinus-Mefailoski, Angelique
Bowden, Peter
Scheltens, Philip
Killestein, Joep
Teunissen, Charlotte
Marshall, John G.

December 2021

Background: A practical strategy to discover proteins specific to Alzheimer’s dementia (AD) may be t...

Extended data for "Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients"

Lim, Bryant

Extended data for "Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patient...

Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

Yuki Kitamura (2259145)
Ryoko Usami (3686107)
Sahoko Ichihara (3431573)
Hirotaka Kida (555666)
Masayuki Satoh (555661)
Hidekazu Tomimoto (110968)
Mariko Murata (2742784)
Shinji Oikawa (1819162)

January 2017

Objectives: Alzheimer’s disease (AD) is the most common cause of dementia in elderly perso...

Protein biomarkers for the diagnosis of Alzheimer's disease at different stages of neurodegeneration

Pérez, Mar
Hernández, Félix
Ávila, Jesús

April 2021

Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...

Are Blood-Based Protein Biomarkers for Alzheimer’s Disease also Involved in Other Brain

Disorders A Systematic Review
Justin Tao
Wen Chiama
Richard James
Butler Dobsonb
Steven John Kiddleb
Martina Sattleckerb C

January 2014

Abstract. Background: Alzheimer’s disease (AD) biomarkers are urgently needed for both early and acc...

Replication study of plasma proteins relating to Alzheimer's pathology.

Shi, L.
Winchester, L.M.
Westwood, S.
Baird, A.L.
Anand, S.N.
Buckley, N.J.
Hye, A.
Ashton, N.J.
Bos, I.
Vos, SJB
Kate, M.T.
Scheltens, P.
Teunissen, C.E.
Vandenberghe, R.
Gabel, S.
Meersmans, K.
Engelborghs, S.
De Roeck, E.E.
Sleegers, K.
Frisoni, G.B.
Blin, O.
Richardson, J.C.
Bordet, R.
Molinuevo, J.L.
Rami, L.
Wallin, A.
Kettunen, P.
Tsolaki, M.
Verhey, F.
Lléo, A.
Sala, I.
Popp, J.
Peyratout, G.
Martinez-Lage, P.
Tainta, M.
Johannsen, P.
Freund-Levi, Y.
Frölich, L.
Dobricic, V.
Legido-Quigley, C.
Barkhof, F.
Andreasson, U.
Blennow, K.
Zetterberg, H.
Streffer, J.
Lill, C.M.
Bertram, L.
Visser, P.J.
Kolb, H.C.
Narayan, V.A.
Lovestone, S.
Nevado-Holgado, A.J.

September 2021

This study sought to discover and replicate plasma proteomic biomarkers relating to Alzheimer's dise...

Candidate Blood Proteome Markers of Alzheimer’s Disease Onset and Progression: A Systematic Review and Replication Study

Steven J. Kiddlea
Martina Sattleckera
Petroula Proitsia
Andrew Simmonsa
Eric Westmanc
Chantal Bazeneta
Sally K. Nelsond
Stephen Williamsd
Angela Hodgesa
Caroline Johnstona
Hilkka Soininene
Iwona Kłoszewskaf
Patrizia Mecoccig
Magda Tsolakih
Bruno Vellasi
Stephen Newhousea
Simon Lovestonea
Richard J. B. Dobsona

January 2013

Abstract. A blood-based protein biomarker, or set of protein biomarkers, that could predict onset an...

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

Payam Emami Khoonsari (3181767)
Anna Häggmark (755022)
Maria Lönnberg (3181770)
Maria Mikus (3181764)
Lena Kilander (470275)
Lars Lannfelt (333066)
Jonas Bergquist (203170)
Martin Ingelsson (252308)
Peter Nilsson (3305)
Kim Kultima (14963)
Ganna Shevchenko (280676)

March 2016

<div>Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of...

Data from: Analysis of the cerebrospinal fluid proteome in Alzheimer's disease

Khoonsari, Payam Emami
Häggmark, Anna
Lönnberg, Maria
Mikus, Maria
Kilander, Lena
Lannfelt, Lars
Bergquist, Jonas
Ingelsson, Martin
Nilsson, Peter
Kultima, Kim
Shevchenko, Ganna

April 2016

Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of dementi...

Summary of previous studies showing changes in acute phase proteins in Alzheimer’s disease.

Tharusha Jayasena (704509)
Anne Poljak (158842)
Nady Braidy (261733)
George Smythe (704510)
Mark Raftery (704511)
Mark Hill (704512)
Henry Brodaty (158887)
Julian Trollor (704513)
Nicole Kochan (704514)
Perminder Sachdev (377263)

March 2015

Summary of previous studies showing changes in acute phase proteins in Alzheimer’s disease.</p

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Sattlecker, Martina
Kiddle, Steven J.
Newhouse, Stephen
Proitsi, Petroula
Nelson, Sally
Williams, Stephen
Johnston, Caroline
Killick, Richard
Simmons, Andrew
Westman, Eric
Hodges, Angela
Soininen, Hilkka
Kłoszewska, Iwona
Mecocci, Patrizia
Tsolaki, Magda
Vellas, Bruno
Lovestone, Simon
Dobson, Richard J.B.

November 2014

AbstractBlood proteins and their complexes have become the focus of a great deal of interest in the ...

IOS Press The use of proteomics in biomarker discovery in neurodegenerative diseases

Pia Davidssona

August 2016

Abstract. Biomarkers for neurodegenerative diseases should reflect the central pathogenic processes ...

Proteomic-based Signature of Brain-related Proteins as Novel Candidate Biomarkers for Alzheimer’s Disease Diagnosis

Begcevic, Ilijana

June 2018

Alzheimer’s disease (AD) is the most common type of dementia characterized by the progressive memory...

Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration

Pérez, Mar
Hernández, Félix
Ávila, Jesús

September 2020

Characterization of functional protein complexes from Alzheimer’s disease and healthy brain by mass spectrometry-based proteome analysis

Beena Hasan
Ayesha Khan
Christof Lenz
Abdul R. Asif
Nikhat Ahmed

July 2021

Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...

The plasma peptides of Alzheimer’s disease

Florentinus-Mefailoski, Angelique
Bowden, Peter
Scheltens, Philip
Killestein, Joep
Teunissen, Charlotte
Marshall, John G.

December 2021

Background: A practical strategy to discover proteins specific to Alzheimer’s dementia (AD) may be t...

Extended data for "Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients"

Lim, Bryant

Extended data for "Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patient...

Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

Yuki Kitamura (2259145)
Ryoko Usami (3686107)
Sahoko Ichihara (3431573)
Hirotaka Kida (555666)
Masayuki Satoh (555661)
Hidekazu Tomimoto (110968)
Mariko Murata (2742784)
Shinji Oikawa (1819162)

January 2017

Objectives: Alzheimer’s disease (AD) is the most common cause of dementia in elderly perso...

Protein biomarkers for the diagnosis of Alzheimer's disease at different stages of neurodegeneration

Pérez, Mar
Hernández, Félix
Ávila, Jesús

April 2021

Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...

Are Blood-Based Protein Biomarkers for Alzheimer’s Disease also Involved in Other Brain

Disorders A Systematic Review
Justin Tao
Wen Chiama
Richard James
Butler Dobsonb
Steven John Kiddleb
Martina Sattleckerb C

January 2014

Abstract. Background: Alzheimer’s disease (AD) biomarkers are urgently needed for both early and acc...

Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

Abstract

Extracted data

Proteins selected from spiked-in normalized data that were verified in the antibody-based analysis as novel disease-associated markers for Alzheimer’s disease.

Abstract

Extracted data

Related items

Related items